Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian J Sworder

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Cancer Cell|October 1, 2021
The landscape of tumor cell states and ecosystems in diffuse large B cell lymphomaChloé B Steen, Bogdan A Luca, Mohammad S Esfahani, et al.
Medrxiv : the Preprint Server for Health Sciences|February 12, 2026
Personalized Circulating Tumor DNA (ctDNA) Profiling Enables Superior and Universal Measurable Residual Disease (MRD) Detection in Acute Myeloid Leukemia (AML)Ruwan Gunaratne, Crystal Zhou, Sanjeeth Rajaram, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2024
Integrative genomic analysis identifies unique immune environments associated with immunotherapy response in diffuse large B cell lymphomaSravya Tumuluru, James K Godfrey, Alan Cooper, et al.
Cancer Discovery|March 20, 2023
Tracing Founder Mutations in Circulating and Tissue-Resident Follicular Lymphoma PrecursorsJoseph G Schroers-Martin, Joanne Soo, Gabriel Brisou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 13, 2025
Remission Assessment by Circulating Tumor DNA in Large B-cell LymphomaMark Roschewski, David M Kurtz, Jason R Westin, et al.
Blood|January 27, 2025
Integrative genomic analysis of DLBCL identifies immune environments associated with bispecific antibody responseSravya Tumuluru, James K Godfrey, Alan Cooper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2021
Short Diagnosis-to-Treatment Interval Is Associated With Higher Circulating Tumor DNA Levels in Diffuse Large B-Cell LymphomaStefan Alig, Charles W Macaulay, David M Kurtz, et al.
Nature Communications|April 23, 2025
IKAROS levels are associated with antigen escape in CD19- and CD22-targeted therapies for B-cell malignanciesPablo Domizi, Jolanda Sarno, Astraea Jager, et al.
Nature Biotechnology|July 23, 2021
Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNADavid M Kurtz, Joanne Soo, Lyron Co Ting Keh, et al.
Nature Biotechnology|April 1, 2022
Inferring gene expression from cell-free DNA fragmentation profilesMohammad Shahrokh Esfahani, Emily G Hamilton, Mahya Mehrmohamadi, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Cancer Cell|October 1, 2021
The landscape of tumor cell states and ecosystems in diffuse large B cell lymphomaChloé B Steen, Bogdan A Luca, Mohammad S Esfahani, et al.
Medrxiv : the Preprint Server for Health Sciences|February 12, 2026
Personalized Circulating Tumor DNA (ctDNA) Profiling Enables Superior and Universal Measurable Residual Disease (MRD) Detection in Acute Myeloid Leukemia (AML)Ruwan Gunaratne, Crystal Zhou, Sanjeeth Rajaram, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2024
Integrative genomic analysis identifies unique immune environments associated with immunotherapy response in diffuse large B cell lymphomaSravya Tumuluru, James K Godfrey, Alan Cooper, et al.
Cancer Discovery|March 20, 2023
Tracing Founder Mutations in Circulating and Tissue-Resident Follicular Lymphoma PrecursorsJoseph G Schroers-Martin, Joanne Soo, Gabriel Brisou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 13, 2025
Remission Assessment by Circulating Tumor DNA in Large B-cell LymphomaMark Roschewski, David M Kurtz, Jason R Westin, et al.
Blood|January 27, 2025
Integrative genomic analysis of DLBCL identifies immune environments associated with bispecific antibody responseSravya Tumuluru, James K Godfrey, Alan Cooper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2021
Short Diagnosis-to-Treatment Interval Is Associated With Higher Circulating Tumor DNA Levels in Diffuse Large B-Cell LymphomaStefan Alig, Charles W Macaulay, David M Kurtz, et al.
Nature Communications|April 23, 2025
IKAROS levels are associated with antigen escape in CD19- and CD22-targeted therapies for B-cell malignanciesPablo Domizi, Jolanda Sarno, Astraea Jager, et al.
Nature Biotechnology|July 23, 2021
Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNADavid M Kurtz, Joanne Soo, Lyron Co Ting Keh, et al.
Nature Biotechnology|April 1, 2022
Inferring gene expression from cell-free DNA fragmentation profilesMohammad Shahrokh Esfahani, Emily G Hamilton, Mahya Mehrmohamadi, et al.
Pageof 3